Watchlist Price Alert

Amphastar Pharmaceuticals... (AMPH)

NASDAQ: AMPH · Real-Time Price · USD

24.67

0.11 (0.45%)

At close: Jun 23, 2025, 3:59 PM

24.68

0.04%

After-hours: Jun 23, 2025, 04:10 PM EDT

Amphastar Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	712.81M	644.39M	498.99M	437.77M	349.85M	322.36M	294.67M	240.18M	255.16M
Cost of Revenue	338.96M	293.27M	250.13M	238.03M	206.51M	190.43M	187.68M	149.38M	150.98M
Gross Profit	373.86M	351.12M	248.86M	199.74M	143.34M	131.92M	106.98M	90.8M	104.19M
Operating Income	205.42M	196.99M	78.76M	43.13M	-14.23M	-39K	-8.62M	-895K	15.69M
Interest Income	10.61M	5.46M	1.32M	601K	642K	997K	456K	425K	270K
Pretax Income	189.76M	171.36M	116.04M	84.14M	4.64M	60.23M	-9.93M	1.62M	14.95M
Net Income	159.52M	137.54M	91.39M	62.12M	1.1M	48.94M	-5.74M	4.51M	10.53M
Selling & General & Admin	94.52M	80.39M	66.59M	68.92M	65.16M	63.11M	58.04M	50.92M	47.3M
Research & Development	73.91M	73.74M	74.77M	60.93M	67.23M	68.85M	57.56M	43.41M	41.2M
Other Expenses	n/a	n/a	8.54M	14.25M	-6.32M	60.27M	-1.3M	2.52M	-746K
Operating Expenses	168.44M	154.13M	141.36M	129.85M	132.39M	131.96M	115.61M	94.33M	88.5M
Interest Expense	30.34M	27.16M	1.85M	885K	374K	119K	243K	826K	1.02M
Selling & Marketing Expenses	37.8M	28.85M	21.53M	17.49M	14.78M	12.83M	8.16M	6.46M	5.47M
Cost & Expenses	507.39M	447.41M	391.49M	367.88M	338.89M	322.4M	303.29M	243.71M	239.47M
Income Tax Expense	29.67M	31.83M	23.48M	20.63M	3.54M	13.72M	-3.27M	-2.88M	4.41M
Shares Outstanding (Basic)	48.43M	48.27M	48.55M	47.78M	47.04M	46.98M	46.4M	46.11M	45.38M
Shares Outstanding (Diluted)	52.06M	53M	52.43M	49.78M	49.12M	49.91M	46.4M	48.37M	47.5M
EPS (Basic)	3.29	2.85	1.88	1.30	0.02	1.04	-0.12	0.10	0.23
EPS (Diluted)	3.06	2.60	1.74	1.25	0.02	0.98	-0.12	0.09	0.22
EBITDA	277.31M	240.29M	107.5M	111.78M	30.19M	81.47M	6.83M	11.9M	30.53M
EBIT	220.11M	198.52M	107.5M	85.02M	5.01M	60.35M	-9.68M	2.08M	15.97M
Depreciation & Amortization	57.2M	41.78M	28.74M	26.75M	25.18M	21.12M	16.52M	15.81M	14.56M